Cytology and Core Biopsy for Cystic Lesions of the Pancreas: A Comparison of Three Cytological Grading Systems.

INTRODUCTION

Cytological appearances may be insufficient to establish the diagnosis of pancreatic cystic lesions, especially for premalignant neoplasms. This study aimed to evaluate three commonly used cytological grading systems [C1-C5, Papanicolaou (Pap), and World Health Organization (WHO) classification systems] in assessing pancreatic cystic lesions.

MATERIALS AND METHODS

A total of 210 pancreatic cytology specimens were classified based on the aforementioned grading systems, 127 of which had supporting histology reported across 6 years, at a single-tertiary referral center.

RESULTS

We excluded 26 cases because of inadequate cytology. The most common cystic lesions were intraductal papillary mucinous neoplasms (IPMNs,  = 71) and pseudocysts ( = 55). Among IPMN, 27 were moderate/high-grade, and 44 were low-grade. There were 12 mucinous cystic neoplasms, 75 benign cysts (pseudocysts, serous cystadenomas, lymphoepithelial cysts, and others), and 15 malignant cases, with 11 cysts being of uncertain etiology. There were 21 high-risk and potentially malignant (WHO grade V) cases in comparison with 42 cases using the C grading (C4 and C5). However, according to Pap grading, 87 had varying risks of malignancy (Category IVB). According to the WHO classification, 63 cases were classified as low-risk pancreaticobiliary neoplasms (WHO grade IV). The remaining cases 85 were benign to very low-risk malignant potential and, therefore, were less likely to be considered for surgical intervention. Diagnostic concordance was higher between cytology and core biopsies in low-grade IPMN.

CONCLUSION

The WHO system provides better risk stratification for neoplasms, optimizing surgical management. However, the C1-C5 system does not recognize cystic lesions with malignant potential.